Hutchmed (China) Limited
(NASDAQ: HCM)
|
5:00 PM UTC, 07/03/24 | |||
---|---|---|---|---|
Last: $17.52 | Change: +0.30 | %Change: +1.74% | Volume: 63,898 |
Open: | $ 17.39 | Volume: | 63,898 | |
---|---|---|---|---|
High: | $ 17.67 | Yield(%) | 0.00 | |
Low: | $ 17.28 | P/E Ratio (ttm): | 29.70 | |
Dividend ($): | n/a | Market Cap ($): | 3.00B | |
EPS ($) | -1.04 | Shares Out: | 174.27M |
% Price Change (last 4 weeks): | -8.79 |
---|---|
% Price Change (last 13 weeks): | 2.99 |
% Price Change (last 26 weeks): | -1.66 |
% Price Change (last 52 weeks): | 45.32 |
% Price Change (year to date): | -4.91 |
Return on Equity (%): | 15.03 |
---|---|
Return on Assets (%): | 8.73 |
Return on Invested Capital (%): | -22.97 |
Gross Profit Margin (%): | 54.12 |
---|---|
Net Profit Margin (%): | 12.03 |
Operating Profit Margin (%): | 2.07 |
|
|
50-day Moving Average: | $18.83 |
---|---|
200-day Moving Average: | $17.23 |
Avg. Daily Vol. (last 50 days): | 111,162 |
Avg. Daily Vol. (last 200 days): | 128,009 |
52-wk high: | $21.92 |
52-wk low: | $11.60 |
Bid: | $17.16 |
Ask: | $18.14 |
HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. It operates through the Oncology/Immunology and Other Ventures segments. The Oncology/Immunology segment includes the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The Other Ventures segment involves the other commercial businesses which include the sales, marketing, manufacture, and distribution of prescription drugs and healthcare products. The company was founded on December 18, 2000 and is headquartered in Hong Kong.
|
Hutchmed (China) Limited
Cheung Kong Center 2 Queen's Road Central 48th Floor Hong Kong Phone: 852.2121.8200 Fax: n/a http://www.hutch-med.com |
Earnings (1year) ($): | 0.57 |
---|---|
Annual Dividend ($): | 0.00 |
Current P/E Ratio (ttm): | 29.70 |
Book Value ($): | 4.19 |
Cash Flow ($): | 0.63 |
Price/Earnings (x): | 29.71 |
---|---|
Price/Sales (x): | 3.76 |
Price/Book (x): | 4.32 |
Price/Cash Flow (x): | 14.36 |
Quick Ratio (x): | 2.60 |
---|---|
Current Ratio (x): | 2.72 |
LT Debt/Equity (x): | 6.99 |
Total Debt/Equity (x): | 11.79 |